Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio, today announced ...

REHOVOT, Israel - CollPlant Biotechnologies (NASDAQ: CLGN), currently valued at $40.7 million in market capitalization, ...

Evolus said the Food and Drug Administration approved its injectable hyaluronic acid gels, known as Evolysse Form and Evolysse Smooth, in line with management expectations.

For decades now, dermal fillers have remained the go-to treatment for fighting the signs of aging, such as lines, wrinkles, ...

Lip filler is becoming more and more popular, but going to a respected and trustworthy healthcare provider is key.